Implications of intratumour heterogeneity for treatment stratification.
about
Translational implications of tumor heterogeneityTheragnostic imaging using radiolabeled antibodies and tyrosine kinase inhibitorsIntratumoral heterogeneity: Clonal cooperation in epithelial-to-mesenchymal transition and metastasisGenomic profiling of breast cancersOpen questions: development of tumor cell heterogeneity and its implications for cancer treatment.Epitope mapping of epidermal growth factor receptor (EGFR) monoclonal antibody and induction of growth-inhibitory polyclonal antibodies by vaccination with EGFR mimotope.Can EGFR mutation status be reliably determined in pre-operative needle biopsies from adenocarcinomas of the lung?Drug-Resistant Urothelial Cancer Cell Lines Display Diverse Sensitivity Profiles to Potential Second-Line Therapeutics.Retreatment with anti-EGFR based therapies in metastatic colorectal cancer: impact of intervening time interval and prior anti-EGFR responseProgrammed death-ligand 1 (PD-L1) characterization of circulating tumor cells (CTCs) in muscle invasive and metastatic bladder cancer patientsChromosomal Instability Estimation Based on Next Generation Sequencing and Single Cell Genome Wide Copy Number Variation Analysis.Intratumoral Heterogeneity of Subcutaneous Nodules in a Never-Smoker Woman of Lung Squamous Cell Carcinoma Detected on 18F-Fluorodeoxyglucose Positron Emission Tomography and Computed Tomography: A Case Report.Intra-tumor genetic heterogeneity in rectal cancerClinical impact of mutation fraction in epidermal growth factor receptor mutation positive NSCLC patientsGenetic and molecular changes in ovarian cancer.The changing landscape of phase I trials in oncology.Metastasis as an evolutionary process.Pathologists and liquid biopsies: to be or not to be?Mutant allele tumor heterogeneity (MATH) and head and neck squamous cell carcinoma.Clinicopathogenomic analysis of mismatch repair proficient colorectal adenocarcinoma uncovers novel prognostic subgroups with differing patterns of genetic evolution.Phenotypic Heterogeneity of Circulating Tumor Cells Informs Clinical Decisions between AR Signaling Inhibitors and Taxanes in Metastatic Prostate Cancer.Establishing the origin of metastatic deposits in the setting of multiple primary malignancies: the role of massively parallel sequencingClinically significant sub-clonality for common drivers can be detected in 26% of KRAS/EGFR mutated lung adenocarcinomas.Defining 'medical necessity' in an age of personalised medicine: A view from Canada.Pathology in drug discovery and development.Progress towards personalized medicine for ameloblastoma.Analytical Validation and Capabilities of the Epic CTC Platform: Enrichment-Free Circulating Tumour Cell Detection and Characterization.
P2860
Q26822823-5DDEFE9C-0CBA-4457-9A44-D4630423E7E0Q26824717-5D18FC8C-F98F-434F-B31D-5E320F153231Q26991480-FE7A479A-622B-41DC-A791-7F6A15F69997Q27013013-5B14B6E0-A8FE-4A82-A40C-B7F1F201D558Q35111833-F8F0D5C9-B335-464B-808F-F31881BD5C46Q35214496-624AC25F-A8B0-4417-BBD4-DEAAD9651CCAQ35537522-DE8D0EBF-8762-4409-B8D0-E7CE5F048933Q35806000-50165543-7FAC-4EA9-9D5F-5545D676A669Q35810693-84F710C3-1413-4942-ABD3-CFB8D23E6183Q36141581-51C449CE-B5FB-4BC6-AB14-18725EB55B5DQ36193912-558D18E0-50E3-4173-A974-5C52160BF5F9Q36193991-90023CD1-0065-4287-8B19-8CE03FFF5AA0Q36414682-BD7E4CD2-4AEF-46BC-9AAA-0C2031A58DE1Q36707731-2E5114A0-2FB5-47EF-97F9-917AAFD8131FQ37094076-1A114335-FFCB-4E2A-8CED-8A188108E956Q38629203-1E8425F6-D4E7-47AC-B8CC-2C6D9891C837Q38819909-B0293F20-A37A-408B-98A0-43BACDF07CF9Q38935060-A19E2E14-F8DA-44E6-96C5-A74871420019Q39025867-85B342EF-5E63-4A0B-9361-F5F696974223Q39754979-CF9F7170-7F4A-4B18-964F-8C1BF124DBD1Q40496979-68085D85-7DF3-4DCA-A603-16F2761C9B61Q41134756-52F96A2B-544F-4BC9-9F1B-98BE20A42379Q41233667-527BF7C0-2D46-475F-8AB2-454D6172D022Q48069953-8406D235-BA65-4BE2-B853-FA812157B556Q48615889-3164ED20-A00F-4BCC-87F7-E9CEBA5FA2C0Q54358697-28263580-905D-484D-B78B-174C36BE954DQ55235329-6A552101-6C31-43A8-A94F-5E2A5E77255E
P2860
Implications of intratumour heterogeneity for treatment stratification.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Implications of intratumour heterogeneity for treatment stratification.
@en
type
label
Implications of intratumour heterogeneity for treatment stratification.
@en
prefLabel
Implications of intratumour heterogeneity for treatment stratification.
@en
P2093
P2860
P356
P1476
Implications of intratumour heterogeneity for treatment stratification.
@en
P2093
Andrew Crockford
James Hicks
Mariam Jamal-Hanjani
P2860
P304
P356
10.1002/PATH.4270
P577
2014-01-01T00:00:00Z